Arcadia Biosciences, Inc.

DB:17D Stock Report

Market Cap: €5.2m

Arcadia Biosciences Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

DB:17D Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
03 Feb 25Buy€1,689Thomas SchaeferIndividual700€2.41
03 Feb 25Buy€1,689Mark KawakamiIndividual700€2.41
01 Aug 24Buy€1,337Thomas SchaeferIndividual700€1.91
01 Aug 24Buy€1,337Mark KawakamiIndividual700€1.91

Insider Trading Volume

Insider Buying: 17D insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 17D?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders11,2140.822%
Institutions146,65010.7%
General Public1,207,07688.4%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 22.9%.

Top Shareholders

Top 20 shareholders own 11.57% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
4.99%
Sabby Management, LLC
68,111€259.2k0%1.79%
1.83%
Mariner, LLC
25,000€95.1k0%no data
1.03%
The Vanguard Group, Inc.
14,038€53.4k0%no data
1.02%
UBS Asset Management AG
13,945€53.1k5,730%no data
0.9%
Geode Capital Management, LLC
12,297€46.8k177%no data
0.89%
State Street Global Advisors, Inc.
12,146€46.2k0%no data
0.37%
Stanley Jacot
5,000€19.0k0%no data
0.21%
Thomas Schaefer
2,819€10.7k33%no data
0.2%
Mark Kawakami
2,681€10.2k35.3%no data
0.044%
Morgan Stanley, Investment Banking and Brokerage Investments
607€2.3k0%no data
0.037%
Kevin Comcowich
500€1.9k0%no data
0.02%
Atticus Wealth Management, LLC
272€1.0k0%no data
0.016%
Lilian Murray
214€814.60%no data
0.0088%
SBI Holdings Inc., Asset Management Arm
120€456.60%no data
0.0055%
Advisor Group Holdings, Inc., Asset Management Arm
75€285.20%no data
0.0013%
Group One Trading LP, Asset Management Arm
18€68.60%no data
0.00081%
Bank of America Corporation, Asset Management Arm
11€42.10%no data
0.00037%
AssetMark, Inc.
5€19.20%no data
0.00029%
Oliver Lagore Vanvalin Investment Group, Inc.
4€15.10%no data
0.00007%
Harbour Investments, Inc.
1€3.60%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/23 07:48
End of Day Share Price 2025/02/21 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Arcadia Biosciences, Inc. is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Benjamin KlieveLake Street Capital Markets, LLC
Jon RitzenthalerPiper Sandler Companies
Brett William WongPiper Sandler Companies